Form 8-K - Current report:
SEC Accession No. 0001641172-25-017264
Filing Date
2025-07-01
Accepted
2025-07-01 06:46:15
Documents
15
Period of Report
2025-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45241
2 EX-99.1 ex99-1.htm EX-99.1 16682
3 GRAPHIC form8-k_001.jpg GRAPHIC 9318
4 GRAPHIC ex99-1_001.jpg GRAPHIC 7091
  Complete submission text file 0001641172-25-017264.txt   266733

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ngvt-20250701.xsd EX-101.SCH 3014
6 XBRL LABEL FILE ngvt-20250701_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE ngvt-20250701_pre.xml EX-101.PRE 22358
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3578
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 251094133
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)